Home/Filings/4/0001562180-24-005019
4//SEC Filing

Brege Laura 4

Accession 0001562180-24-005019

CIK 0001710072other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 7:25 PM ET

Size

5.6 KB

Accession

0001562180-24-005019

Insider Transaction Report

Form 4
Period: 2024-06-10
Brege Laura
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-10+20,59420,594 total
    Exercise: $17.13From: 2025-06-10Exp: 2034-06-10Common Stock (20,594 underlying)
Footnotes (1)
  • [F1]100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders.

Issuer

Edgewise Therapeutics, Inc.

CIK 0001710072

Entity typeother

Related Parties

1
  • filerCIK 0001365619

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 7:25 PM ET
Size
5.6 KB